Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.
LATEST LEUKEMIAS CONTENT
Evolving Approaches to BTK Inhibitor Therapy in CLL
Experts Weigh Fixed-Duration Approaches in Frontline CLL
Individualizing Fixed-Duration Therapy in Treatment-Naive CLL
Experts Consider New Data, New BTKi Choices in Frontline CLL
Imetelstat Improves Outcomes in Heavily Transfusion-Dependent MDS
Duration of Response Contributes to Survival in COMMANDS Trial in MDS
Understanding the Role of Mutations in Staging of Low-Risk MDS
Targeted Therapy for BPDCN Provides Path to Allogeneic Transplant
CASE-BASED ROUNDTABLES
Advertisement
Advertisement